Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attackYuan Fang, Ying–Hong Shi, Weiren Liu et al.|Hepatology|2022Cited by 158
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resectionWei‐Feng Qu, Ying–Hong Shi, Wei‐Ren Liu et al.|Annals of Translational Medicine|2020Cited by 49
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinomaMeng‐Xin Tian, Ying–Hong Shi, Wei‐Ren Liu et al.|BMC Medicine|2019Cited by 44
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGuiqi Zhu, Ying–Hong Shi, Weiren Liu et al.|Molecular Oncology|2021Cited by 44
Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS<sub>ICC</sub>‐applied prediction modelMeng‐Xin Tian, Ying–Hong Shi, Weiren Liu et al.|Cancer Science|2020Cited by 24